Selene Therapeutics

Epilepsy Therapy

Health Tech & Life Sciences
Active
Seed , Israel Founded 2020
Last updated 2026-06-18
Total raised
Last: 2024-06
Stage
Seed
Founded
2020
Headcount
1
HQ
, Israel
Sector
Health Tech & Life Sciences

About

Selene Therapeutics is developing a new therapeutic strategy for treating refractory epilepsy by regulating the neuronal activity set point by reducing the neuronal mean firing rate. Selene aims to develop small molecules for inhibitors of dihydroorotate dehydrogenase, a mitochondrial enzyme located on the inner mitochondrial membrane that participates in several key cellular homeostatic processes. The company is part of the FuturX biotech incubator in Ness Ziona.

Funding history · 2 rounds · — total

Q&A

What is Selene Therapeutics' primary focus?
Selene Therapeutics is developing a new therapeutic strategy for treating refractory epilepsy by regulating neuronal activity to reduce the neuronal mean firing rate.
What type of molecules is Selene Therapeutics developing?
Selene Therapeutics aims to develop small molecules that act as inhibitors of dihydroorotate dehydrogenase, a mitochondrial enzyme involved in cellular homeostatic processes.
When was Selene Therapeutics founded?
Selene Therapeutics was founded in September 2020.
How many employees does Selene Therapeutics have?
Selene Therapeutics has 1-10 employees.
Which incubator is Selene Therapeutics part of?
Selene Therapeutics is part of the FuturX biotech incubator in Ness Ziona, Israel.
Who are the founders of Selene Therapeutics?
The founders of Selene Therapeutics are Inna Slutsky and Neta Pessah.
What was Selene Therapeutics' most recent funding event?
In June 2024, Selene Therapeutics received funding from the Israel Innovation Authority.
Which investors participated in Selene Therapeutics' October 2020 funding round?
In October 2020, Selene Therapeutics received funding from RMGP Biopharma Investment Fund and FutuRx.

Team · 2

Founder · Founder
LinkedIn ↗
Founder · CSO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Tags

epilepsydrug-developmenttreatmentspharmaceuticalsneurology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)